Our investigation into IDH-mutant astrocytoma demonstrated slightly lower EOA on average with higher complications, though it is difficult to draw any robust conclusions from this cohort given its extremely limited size of just 21 patients. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).